The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus
- Affiliated Author(s)
- 손창남; 이원목; 김지민; 김상현
- Alternative Author(s)
- Kim, Ji Min; Kim, Sang Hyon; Son, Chang Nam; Lee, Won Mok
- Journal Title
- Korean J Intern Med
- ISSN
- 1226-3303
- Issued Date
- 2018
- Keyword
- Systemic lupus erythematosus; Anti-C-reactive protein antibody
- Abstract
- Background/Aims
Anti-C-reactive protein (CRP) antibody has been introduced as a potential biologic marker in Systemic lupus erythematosus (SLE). The aim of study is to evaluate the level of anti-CRP antibody in patients with SLE.
Methods
This study investigated the relationship between levels of anti-CRP antibodies and disease activity markers, such as complement, anti-double-stranded DNA antibody, and SLE disease activity index in 34 patients with SLE.
Results
The serum anti-CRP antibody levels of the patients with SLE were significantly higher than those of the healthy controls (11.3 ± 5.6 µg/mL vs. 9.1 ± 2.8 µg/mL). The percentages of the positive anti-CRP antibody were 52.9% in SLE and 27.8% in controls. Disease duration of SLE showed significant correlation with the anti-CRP antibody (r = 0.234, p = 0.026). However no significant relationship was observed between the levels of anti-CRP antibodies and disease activity markers.
Conclusions
These data show that the anti-CRP antibody levels of the patients with SLE were significantly higher than those of healthy controls. We observed that the presence of the anti-CRP anti-CRP antibody was not associated with disease activity of SLE.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.